SANA
Sana Biotechnology Inc

4,105
Mkt Cap
$888.67M
Volume
2.43M
52W High
$6.55
52W Low
$1.26
PE Ratio
-3.41
SANA Fundamentals
Price
$3.29
Prev Close
$3.33
Open
$3.38
50D MA
$4.24
Beta
2.00
Avg. Volume
1.97M
EPS (Annual)
-$0.9642
P/B
5.52
Rev/Employee
$0.00
$966.95
Loading...
Loading...
News
all
press releases
Sana Biotechnology (SANA) Expected to Announce Quarterly Earnings on Monday
Sana Biotechnology (NASDAQ:SANA) will be releasing its Q4 2025 earnings before the market opens on Monday, March 16. (View Earnings Report at...
MarketBeat·2d ago
News Placeholder
More News
News Placeholder
Q1 EPS Estimate for Sana Biotechnology Lowered by Analyst
Sana Biotechnology, Inc. (NASDAQ:SANA - Free Report) - Equities research analysts at HC Wainwright dropped their Q1 2026 EPS estimates for Sana Biotechnology in a report issued on Wednesday, March...
MarketBeat·4d ago
News Placeholder
Sana Biotechnology (NASDAQ:SANA) Stock Price Down 9.7% After Analyst Downgrade
Sana Biotechnology (NASDAQ:SANA) Trading Down 9.7% Following Analyst Downgrade...
MarketBeat·5d ago
News Placeholder
What is HC Wainwright's Forecast for SANA FY2030 Earnings?
Sana Biotechnology, Inc. (NASDAQ:SANA - Free Report) - Analysts at HC Wainwright issued their FY2030 earnings estimates for Sana Biotechnology in a report issued on Wednesday, March 4th. HC...
MarketBeat·5d ago
News Placeholder
Sana Biotechnology (NASDAQ:SANA) Cut to Hold at Zacks Research
Zacks Research lowered shares of Sana Biotechnology from a "strong-buy" rating to a "hold" rating in a report on Tuesday...
MarketBeat·5d ago
News Placeholder
Sana Biotechnology (NASDAQ:SANA) Price Target Lowered to $7.00 at HC Wainwright
HC Wainwright reduced their target price on Sana Biotechnology from $9.00 to $7.00 and set a "buy" rating for the company in a research note on Wednesday...
MarketBeat·6d ago
News Placeholder
Sana Biotechnology, Inc. (NASDAQ:SANA) Given Consensus Recommendation of "Moderate Buy" by Analysts
Sana Biotechnology, Inc. (NASDAQ:SANA - Get Free Report) has received a consensus recommendation of "Moderate Buy" from the nine analysts that are covering the firm, Marketbeat reports. One equities...
MarketBeat·12d ago
News Placeholder
Genomics Stocks That Deserve a Place in Your Portfolio in 2026
Genomics and synthetic biology are reshaping healthcare, as rapid DNA sequencing advances power personalized medicine and strong market growth.
Zacks·18d ago
News Placeholder
Sana Biotechnology Announces Appointment Of Brian Piper As CFO
(RTTNews) - Sana Biotechnology, Inc. (SANA), Tuesday announced the appointment of Brian Piper as Executive Vice President and Chief Financial Officer of the company...
Nasdaq News: Markets·21d ago
News Placeholder
Sana Biotechnology (NASDAQ:SANA) Downgraded by Wall Street Zen to Sell
Wall Street Zen lowered Sana Biotechnology from a "hold" rating to a "sell" rating in a report on Saturday...
MarketBeat·1mo ago
<
1
2
...
>

Latest SANA News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.